vaccines

Documents about vaccines

• Safety Study of GBS Following Menactra Meningococcal Vaccination#1030604ClinicalTrials.gov
• Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population#394603ClinicalTrials.gov
• Lot-to-lot Consistency of Sci-B-Vac™ in Adults#432916ClinicalTrials.gov
• Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23#424247ClinicalTrials.gov
• Immunogenicity and Safety of Sci-B-Vac® to Engerix-B® in Adults#373649ClinicalTrials.gov
• Access to adult vaccines in Kenya: a case study of COVID-19 vaccines#956249SU+ Digital Repository
• Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products#833901ClinicalTrials.gov
• MAS-1 Adjuvanted Compared to Unadjuvanted Influenza Vaccines in the Elderly#332809ClinicalTrials.gov
• WHO position paper on COVID-19 vaccines, July 2026#419737WHO IRIS
• Understanding the Immune Response to Two Different Meningitis Vaccines#862599ClinicalTrials.gov
• Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children#1009011ClinicalTrials.gov
• A case study on the ecosystem for local production of pharmaceuticals, vaccines and biologicals: the Tunisia context#279019WHO IRIS
• Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™#234484ClinicalTrials.gov
• An Effectiveness Study of the Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine#887609ClinicalTrials.gov
• DEVELOPMENT AND COMPARISON OF VSV AND MRNA VACCINES FOR MACHUPO VIRUS#929414ScholarlyCommons
• COVID-19 mortality risk among people with HIV in Florida before and after the introduction of COVID-19 vaccines: A population-based study#1001738PLOS
• What are the evidence-based guidelines for delivering vaccines via intradermal administration?#14665DataCite
• What are the evidence-based guidelines for delivering vaccines via intradermal administration?#14666DataCite
• SAFETY, EFFICACY, AND IMMUNOGENICITY OF SARS-COV-2 MRNA VACCINES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS#334543ScholarBank@NUS
• Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 Vaccine#432929ClinicalTrials.gov
• Meningococcal disease epidemiology – United States, 2020–2023#626368PLOS
• Antibody Responses to Pneumococcal Vaccines Among HIV-infected Adults.#1073980ClinicalTrials.gov
• Pandemic Influenza Plasmid DNA Vaccines (Needle)#136400ClinicalTrials.gov
• Vaccines as Global Health Security Infrastructure: Insights from a Descriptive Analysis of Vaccines Europe Members' Clinical Pipelines.#232274NCBI PubMed Central
• Development and Evaluation of Lipid Nanoparticle-encapsulated DNA Vaccines for Avian Influenza in Chickens#442277DigitalCommons@University of Nebraska
• Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines#854191ClinicalTrials.gov
• Study to Evaluate Safety, Tolerability and Immunogenicity of a Bedside Mixing Combination of Two Adjuvanted Influenza Vaccines#829580ClinicalTrials.gov
• A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART)#1047917ClinicalTrials.gov
• HHSD200200928656C — SANOFI VACCINES US INC. — Department of Health and Human Services ($737,348,871)#605604USAspending
• HHSD200201033940C — SANOFI VACCINES US INC. — Department of Health and Human Services ($709,203,249)#605685USAspending
• Preventive vaccines for cervical cancer#285700Redalyc
• Pandemic Influenza Plasmid DNA Vaccines (Needle-Free)#441954ClinicalTrials.gov
• Clinical research progress and challenges of vaccine for human papillomavirus-associated cancers#234970Europe PMC
• Estimate the Safety and Effectiveness of Adjuvanted Influenza Vaccine Among Asian Elderly People When Compared to Non-adjuvanted Vaccines#311175ClinicalTrials.gov
• RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults#808012ClinicalTrials.gov
• Immune Responses Induced by Different Licensed Influenza Vaccines#881130ClinicalTrials.gov
• Acetaminophen Before Vaccines for Infants Study (AVIS)#356521ClinicalTrials.gov
• Therapeutic approaches against dengue virus: current status of vaccines, antivirals, and monoclonal antibodies.#309484PubMed
• Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines#346974ClinicalTrials.gov
• Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo#426628ClinicalTrials.gov
• Safety Study of an Additional MVA Vaccine in Volunteers Who Received 3 DNA Vaccines Followed by 2 MVA Vaccines#467616ClinicalTrials.gov
• Repurposing licensed viral vaccines as anti-cancer therapeutics: Turning cold tumors hot#478495Europe PMC
• Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 Months#853527ClinicalTrials.gov
• COVID-19 Vaccines and the Development of New LUTS#874443ClinicalTrials.gov
• Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old#903186ClinicalTrials.gov
• Safety and Reactogenicity Trial of Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae Type b#363649ClinicalTrials.gov
• Vaccine Chatbot for Improving Influenza Vaccination Uptake#123560ClinicalTrials.gov
• Community Pharmacists Vaccinate Against Cancer#628566ClinicalTrials.gov
• Basis of ethical obligation? Covid-19 vaccines#727731PhilArchive
• Persistency Study After Hib-CRM (Cross-Reacting Material)197 or Hib-TT (Tetanus Toxoid) Vaccines in Chinese Children#268078ClinicalTrials.gov

Related topics